Gerhard Mueller-Schwefe

496 total citations
17 papers, 356 citations indexed

About

Gerhard Mueller-Schwefe is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Physiology. According to data from OpenAlex, Gerhard Mueller-Schwefe has authored 17 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Anesthesiology and Pain Medicine and 7 papers in Physiology. Recurrent topics in Gerhard Mueller-Schwefe's work include Pain Management and Opioid Use (9 papers), Musculoskeletal pain and rehabilitation (7 papers) and Pain Mechanisms and Treatments (6 papers). Gerhard Mueller-Schwefe is often cited by papers focused on Pain Management and Opioid Use (9 papers), Musculoskeletal pain and rehabilitation (7 papers) and Pain Mechanisms and Treatments (6 papers). Gerhard Mueller-Schwefe collaborates with scholars based in Italy, Germany and Spain. Gerhard Mueller-Schwefe's co-authors include Michael A. Ueberall, Ute Essner, B Terhaag, E. Reig, Michael A. Überall, Samuel J. Hassenbusch, F Titus, Robert Lange, Lorenzo Pinessi and Gennaro Bussone and has published in prestigious journals such as Cephalalgia, European Journal of Pain and Pain Medicine.

In The Last Decade

Gerhard Mueller-Schwefe

16 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerhard Mueller-Schwefe Italy	10	141	123	93	86	84	17	356
Eberhard A. Lux Germany	9	262 1.9×	80 0.7×	136 1.5×	38 0.4×	29 0.3×	37	539
Christian Cloutier Canada	6	193 1.4×	168 1.4×	115 1.2×	42 0.5×	52 0.6×	7	352
Jan‐Peter Jansen Germany	15	57 0.4×	200 1.6×	130 1.4×	318 3.7×	213 2.5×	16	621
Xiulu Ruan United States	9	137 1.0×	76 0.6×	123 1.3×	23 0.3×	141 1.7×	24	421
Hardo Sorgatz Germany	7	131 0.9×	85 0.7×	150 1.6×	40 0.5×	18 0.2×	18	305
Ana Cristina Mangas Italy	8	224 1.6×	111 0.9×	141 1.5×	63 0.7×	38 0.5×	8	407
G. Vorsanger United States	15	241 1.7×	280 2.3×	228 2.5×	50 0.6×	30 0.4×	29	640
Anthony J. Mariano United States	9	112 0.8×	158 1.3×	110 1.2×	23 0.3×	87 1.0×	19	384
Ilona Steigerwald Germany	13	311 2.2×	552 4.5×	190 2.0×	33 0.4×	53 0.6×	20	728
Anh L. Ngo United States	11	40 0.3×	94 0.8×	49 0.5×	45 0.5×	26 0.3×	19	372

Countries citing papers authored by Gerhard Mueller-Schwefe

Since Specialization

Citations

This map shows the geographic impact of Gerhard Mueller-Schwefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Mueller-Schwefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Mueller-Schwefe more than expected).

Fields of papers citing papers by Gerhard Mueller-Schwefe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Mueller-Schwefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Mueller-Schwefe. The network helps show where Gerhard Mueller-Schwefe may publish in the future.

Co-authorship network of co-authors of Gerhard Mueller-Schwefe

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Mueller-Schwefe. A scholar is included among the top collaborators of Gerhard Mueller-Schwefe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Mueller-Schwefe. Gerhard Mueller-Schwefe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ueberall, Michael A., et al.. (2021). Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry. Pain Medicine. 23(4). 745–760. 8 indexed citations

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2021). COMET – effectiveness and tolerability of methocarbamol versus oral opioid-analgesics as add-on measure in patients with non-specific low back pain refractory to recommended 1st line treatments. A retrospective analysis of depersonalized propensity score matched open-label real-world 4-week data from the German Pain e-Registry. Current Medical Research and Opinion. 38(2). 237–253. 2 indexed citations

Ueberall, Michael A., Ute Essner, & Gerhard Mueller-Schwefe. (2019). <p>Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry</p>. Journal of Pain Research. Volume 12. 1577–1604. 48 indexed citations

Ueberall, Michael A., et al.. (2016). Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice. International Journal of General Medicine. 9. 39–39. 8 indexed citations

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2016). Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations. Journal of Pain Research. Volume 9. 1001–1020. 17 indexed citations

Ueberall, Michael A., Gerhard Mueller-Schwefe, R. Wigand, & Ute Essner. (2016). Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials. Journal of Pain Research. Volume 9. 941–961. 11 indexed citations

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2015). Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids. Journal of Pain Research. 8. 459–459. 9 indexed citations

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2015). Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations. Current Medical Research and Opinion. 31(7). 1413–1429. 28 indexed citations

Ueberall, Michael A., et al.. (2015). Physicians Experience with and Expectations of the Safety and Tolerability of WHO-Step III Opioids for Chronic (Low) Back Pain: Post Hoc Analysis of Data from a German Cross-Sectional Physician Survey. Pain Research and Treatment. 2015. 1–8. 1 indexed citations

10.

Überall, Michael A., Gerhard Mueller-Schwefe, & B Terhaag. (2012). Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study. Current Medical Research and Opinion. 28(10). 1617–1634. 44 indexed citations

11.

Ueberall, Michael A., Gerhard Mueller-Schwefe, & B Terhaag. (2011). Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain – results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials. International Journal of Clinical Pharmacology and Therapeutics. 49(11). 637–647. 13 indexed citations

12.

Mueller-Schwefe, Gerhard & Michael A. Ueberall. (2006). 704 OXYCODONE IN DAILY PRACTICE — FULFILLING UNMEET NEEDS AND ADRESSING INDIVIDUAL EXPECTATIONS OF PATIENTS SUFFERING FROM SEVERE CHRONIC PAIN. European Journal of Pain. 10(S1). 1 indexed citations

13.

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2006). 705 INDIVIUDAL TREATMENT TARGETS IN CHRONIC PAIN MANAGEMENT. European Journal of Pain. 10(S1). 1 indexed citations

14.

Ueberall, Michael A. & Gerhard Mueller-Schwefe. (2006). 656 OPIOID‐INDUCED CONSTIPATION — A FREQUENT AND DISTRESSING SIDE EFFECT IN DAILY PRACTICE AFFECTING ORAL AND TRANSDERMAL OPIOID APPLICATIONS. European Journal of Pain. 10(S1). 24 indexed citations

15.

Diener, HC, Gennaro Bussone, A. Eikermann, et al.. (2004). Placebo-Controlled Comparison of Effervescent Acetylsalicylic Acid, Sumatriptan and Ibuprofen in the Treatment of Migraine Attacks. Cephalalgia. 24(11). 947–954. 79 indexed citations

16.

Mueller-Schwefe, Gerhard. (2003). [Flupirtine in acute and chronic pain associated with muscle tenseness. Results of a postmarket surveillance study].. PubMed. 121(1). 11–49. 16 indexed citations

17.

Mueller-Schwefe, Gerhard, Samuel J. Hassenbusch, & E. Reig. (1999). Cost Effectiveness of Intrathecal Therapy for Pain. Neuromodulation Technology at the Neural Interface. 2(2). 77–84. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact